(Q63814218)
Statements
A Phase IV, Multicenter, Open-Label Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases (PID) in Children and Adolescents (English)
0 references
March 2011
0 references
April 2014
0 references
25
0 references
2 year
0 references
16 year
0 references